Keywords
Alzheimer's Disease
Nutrition
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To describe the benefits of the fasting-mimicking diet in the treatment of Alzheimer's Disease. Literature review: Alzheimer's Disease is a progressive, multifactorial neurodegenerative disorder characterized by a decline in cognitive functions. In this context, the fasting-mimicking diet stands out, known for its caloric restriction and intake of exclusively plant-based foods, including low levels of sugar, proteins, and high levels of unsaturated fats. This diet aims to reproduce the effects of fasting in an individual who is eating. Its effects on the body occur through the activation of an alternative metabolic pathway, bringing notable benefits such as the reduction of inflammation, the promotion of autophagy and cellular cleansing, the reduction of beta-amyloid, and the decrease of oxidative stress. Final considerations: The fasting-mimicking diet contributes to the improvement of dementia caused by Alzheimer's Disease, indicating a possible treatment option.
References
BOCCARDI V, et al. The Potential of Fasting-mimicking Diet as a Preventive and Curative Strategy for Alzheimer's Disease. Biomolecules, 2023; 13: 1133.
BRANDHORST S, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism, 2015; 22: 86–99.
BRANDHORST S, et al. Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. Nature Communications, 2024; 15(1).
CALSOLARO V e EDISON P. Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 2016; 12: 719–732.
CHOI IY, et al. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence. Molecular and Cellular Endocrinology, 2017; 455: 4–12.
DE GROOT S, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature communications, 2020; 11(1): 3083.
DENG Y, et al. Alzheimer’s disease with frailty: Prevalence, screening, assessment, intervention strategies and challenges. Bioscience trends, 2023; 17: 283–292.
GOURAS GK, et al. β-Amyloid peptides and amyloid plaques in Alzheimer’s disease. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics, 2015; 12: 3–11.
GUTIERREZ BAO, et al. Economic impact of Alzheimer’s Disease in Brazil: is it possible to improve care and minimize costs? Ciência & Saúde Coletiva, 2014; 19: 4479–4486.
GRANT WB e BLAKE SM. Diet’s role in modifying risk of Alzheimer’s disease: History and present understanding. Journal of Alzheimer’s disease: JAD, 2023; 96(4): 1353–1382.
JIANG Z, et al. Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases. Aging and Disease, 2022; 13(4): 1146.
KHAN S, et al. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer’s disease. Current Neuropharmacology, 2022; 18: 1106–1125.
LEI P, et al. The essential elements of Alzheimer’s disease. The Journal of Biological Chemistry, 2020; 296: 1-28.
LI T, et al. Fasting-mimicking diet alleviates inflammatory pain by inhibiting neutrophil extracellular traps formation and neuroinflammation in the spinal cord. Cell communication and signaling: CCS, 2023; 21(1): 2-25.
LOBO F, et al. The effects of dietary interventions on brain aging and neurological diseases. Nutrients, 2022; 14: 5086.
LONGO V. The longevity diet: Slow aging, fight disease, optimize weight. Nova Iorque, NY, USA: Avery Publishing Group, 2019; 45p.
LONGO V, et al. Intermittent and periodic fasting, longevity and disease. Nature Aging, 2021; 1: 47–59.
MATTSON MP, et al. Impact of intermittent fasting on health and disease processes. Ageing research reviews, 2017; 39: 46–58.
PHILLIPS MCL. Fasting as a therapy in neurological disease. Nutrients, 2019; 11: 2501.
RANGAN P, et al. Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer’s models. Cell reports, 2022; 40: 111417.
SCHELTENS P, et al. Alzheimer’s disease. Lancet, 2021; 397 1577–1590.
SOARES NM, et al. Economic impact and prevalence of Alzheimer’s disease in a Brazilian capital. Ciência & Saúde, 2017; 10: 133.
STRAC DS, et al. Personalizing the care and treatment of Alzheimer’s disease: An overview. Pharmacogenomics and Personalized Medicine, 2021; 14: 631-653.
TAHAMI MAA, et al. Alzheimer’s disease: Epidemiology and clinical progression. Neurology and Therapy, 2022; 11: 553–569.
ZHANG J, et al. Intermittent fasting protects against Alzheimer’s disease possibly through restoring aquaporin-4 polarity. Frontiers in Molecular Neuroscience, 2017; 10.
ZENG Z, et al. Fasting, a Potential Intervention in Alzheimer's Disease. Journal of Integrative Neuroscience, 2024; 23(3): 50.